103775-14-0,MFCD08063675
Catalog No.:AA008WRU

103775-14-0 | MOEXIPRILAT HYDRATE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$130.00   $91.00
- +
5mg
≥95%
in stock  
$488.00   $341.00
- +
10mg
≥95%
in stock  
$909.00   $636.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008WRU
Chemical Name:
MOEXIPRILAT HYDRATE
CAS Number:
103775-14-0
Molecular Formula:
C25H30N2O7
Molecular Weight:
470.5149
MDL Number:
MFCD08063675
SMILES:
COc1cc2C[C@@H](C(=O)O)N(Cc2cc1OC)C(=O)[C@@H](N[C@H](C(=O)O)CCc1ccccc1)C
Properties
Computed Properties
 
Complexity:
711  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
10  
XLogP3:
0.5  

Literature

Title: Metabolism of moexipril to moexiprilat: determination of in vitro metabolism using HPLC-ES-MS.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates)) 20070101

Title: Monitoring the metabolism of moexipril to moexiprilat using high-performance liquid chromatography-electrospray ionization mass spectrometry.

Journal: Journal of chromatographic science 20060401

Title: The influence of oestrogen-deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive rats.

Journal: European journal of heart failure 20051201

Title: Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.

Journal: International journal of clinical pharmacology and therapeutics 20020101

Title: Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.

Journal: Arzneimittel-Forschung 19970201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:103775-14-0 Molecular Formula|103775-14-0 MDL|103775-14-0 SMILES|103775-14-0 MOEXIPRILAT HYDRATE
Catalog No.: AA008WRU
103775-14-0,MFCD08063675
103775-14-0 | MOEXIPRILAT HYDRATE
Pack Size: 1mg
Purity: ≥95%
in stock
$130.00 $91.00
Pack Size: 5mg
Purity: ≥95%
in stock
$488.00 $341.00
Pack Size: 10mg
Purity: ≥95%
in stock
$909.00 $636.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008WRU
Chemical Name: MOEXIPRILAT HYDRATE
CAS Number: 103775-14-0
Molecular Formula: C25H30N2O7
Molecular Weight: 470.5149
MDL Number: MFCD08063675
SMILES: COc1cc2C[C@@H](C(=O)O)N(Cc2cc1OC)C(=O)[C@@H](N[C@H](C(=O)O)CCc1ccccc1)C
Properties
Complexity: 711  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 3  
Heavy Atom Count: 34  
Hydrogen Bond Acceptor Count: 8  
Hydrogen Bond Donor Count: 3  
Rotatable Bond Count: 10  
XLogP3: 0.5  
Literature fold

Title: Metabolism of moexipril to moexiprilat: determination of in vitro metabolism using HPLC-ES-MS.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))20070101

Title: Monitoring the metabolism of moexipril to moexiprilat using high-performance liquid chromatography-electrospray ionization mass spectrometry.

Journal: Journal of chromatographic science20060401

Title: The influence of oestrogen-deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive rats.

Journal: European journal of heart failure20051201

Title: Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.

Journal: International journal of clinical pharmacology and therapeutics20020101

Title: Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.

Journal: Arzneimittel-Forschung19970201

Building Blocks More >
117657-38-2
117657-38-2
1H-PYRROLE-1-CARBOXYLIC ACID, 2,5-DIBROMO-, 1,1-DIMETHYLETHYL ESTER
AA008WZD | MFCD11112105
115966-68-2
115966-68-2
Histatin 5
AA008X8J
1175036-51-7
1175036-51-7
1-(4-Hydroxyphenyl)piperazine hydrochloride
AA008XKJ | MFCD08059228
1149804-35-2
1149804-35-2
4,4,5,5-Tetramethyl-2-[10-(1-naphthyl)anthracen-9-yl]-1,3,2-dioxaborolane
AA008XY9 | MFCD30470497
108310-79-8
108310-79-8
Thiazolo[5,4-c]pyridin-2-amine
AA008YC5 | MFCD09909658
1123171-93-6
1123171-93-6
Methyl 3-bromo-5-fluoro-4-nitrobenzoate
AA008YZS | MFCD14635859
1003043-76-2
1003043-76-2
6-Bromo-4-chloro-2-(methylsulfanyl)quinazoline
AA008Z8A | MFCD11044642
112736-14-8
112736-14-8
6-Ethylpicolinimidamide hydrochloride
AA008ZT8 | MFCD12755688
1138444-10-6
1138444-10-6
2-Chloro-3-((trimethylsilyl)ethynyl)pyridin-4-amine
AA0090EU | MFCD11857680
1185296-02-9
1185296-02-9
1-(Pyrimidin-2-yl)piperidine-3-carboxylic acid hydrochloride
AA0090R6 | MFCD06801270
Submit
© 2017 AA BLOCKS, INC. All rights reserved.